SCHEMBL4864372

SCHEMBL4864372

Cc1cccc(-c2c(-c3ccc4c(c3)OCO4)nc3ccccn23)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.53
MAPT P10636 7/20 0.53
TP53 P04637 2/20 0.53
TGFBR1 P36897 10/20 0.52
MAPK14 Q16539 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
RIPK2 O43353 1/20 0.52
ACVR1B P36896 1/20 0.52
KDM4E B2RXH2 7/20 0.50
ALDH1A1 P00352 6/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
HPGD P15428 4/20 0.50
RAB9A P51151 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
NPC1 O15118 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
PKM P14618 1/20 0.50
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4863284 0.83 KDM4E (0.64) GAAMAPTTP53TGFBR1MAPK14
SCHEMBL4877207 0.78 TGFBR1 (0.49) MAPTTGFBR1MAPK14TDP1RIPK2
SCHEMBL18584468 0.77 MAPT (0.53) GAAMAPTTP53TDP1KDM4E
SCHEMBL15849494 0.77 TGFBR1 (0.62) GAAMAPTTGFBR1MAPK14TDP1
SCHEMBL4866077 0.76 TGFBR1 (0.52) GAAMAPTTGFBR1MAPK14SMN1; SMN2
SCHEMBL8816383 0.73 TGFBR1 (0.66) GAAMAPTTP53TGFBR1MAPK14
SCHEMBL4872959 0.73 TGFBR1 (0.48) MAPTTGFBR1MAPK14TDP1RIPK2
SCHEMBL4032592 0.72 TGFBR1 (0.55) GAAMAPTTP53TGFBR1MAPK14
SCHEMBL4030943 0.72 TGFBR1 (0.57) GAAMAPTTGFBR1MAPK14TDP1
SCHEMBL24479292 0.72 AKT1 (0.43) MAPTKDM4EALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275235-A1 NOVEL FUSED HETEROAROMATIC COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS PFIZER INC. (US) 2008-11-06 US disclosed
US-7417041-B2 Imidazopyrimidines as transforming growth factor (TGF) inhibitors PFIZER INC. (US) 2008-08-26 US disclosed
US-20040176390-A1 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors PFIZER INC 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275235-A1 NOVEL FUSED HETEROAROMATIC COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS TGFBR1, SMAD3, SMAD2 GAA 924/4885MAPT 1553/4885TP53 171/4885
US-20040176390-A1 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors SMAD3, TGFBR1, SMAD2 GAA 864/4885MAPT 2086/4885TP53 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.